Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  FIRST NORTH STOCKHOLM  >  Biovica International AB (publ)    BIOVIC B   SE0008613731

BIOVICA INTERNATIONAL AB (PUBL)

(BIOVIC B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about BIOVICA INTERNATIONAL AB (PUBL)
11/23BIOVICA INTERNATIONAL : DiviTum®TKa included in new UK breast cancer study
AQ
11/20BIOVICA INTERNATIONAL : Multicenter study PYTHIA presents positive DiviTum®TKa r..
AQ
11/19BIOVICA INTERNATIONAL : CDK 4/6 dosing study supports DiviTum®TKa as an early an..
AQ
11/18BIOVICA INTERNATIONAL : announces initial results in clinical genomics study of ..
AQ
11/17BIOVICA INTERNATIONAL : DiviTum®TKa Monitoring Capabilities Confirmed in SWOG St..
AQ
11/13BIOVICA INTERNATIONAL : FDA submission will proceed to substantive review
AQ
10/30BIOVICA INTERNATIONAL : FDA resource reallocation impacts DiviTum®TKa timeline
AQ
10/23BIOVICA INTERNATIONAL : DiviTum®TKa in four posters at SABCS
AQ
09/25BIOVICA INTERNATIONAL : completes 510(k) submission for DiviTum®TKa to the FDA
AQ
08/27BIOVICA INTERNATIONAL : Bulletin from the annual general meeting in Biovica
AQ
08/27BIOVICA Q1 INTERIM REPORT : May-July 2020/2021
AQ
08/26BIOVICA INTERNATIONAL : carries out a directed share issue of Class B shares and..
AQ
08/26BIOVICA INTERNATIONAL : intends to carry out a directed share issue of Class B s..
AQ
08/26BIOVICA INTERNATIONAL : successfully completes clinical validation for DiviTum® ..
AQ
07/22BIOVICA INTERNATIONAL PUBL : Notice to AGM for Biovica International AB
AQ
06/30BIOVICA INTERNATIONAL AB : – Annual Report for the fiscal year 2019/2020 p..
AQ
06/17BIOVICA INTERNATIONAL PUBL : completes analytical validation as part of FDA appl..
AQ
06/05Biovica Year-end Report for 2019/2020
AQ
05/22BIOVICA INTERNATIONAL PUBL : DiviTum® acknowledged in ASCO educational book
AQ
05/11BIOVICA INTERNATIONAL PUBL : DiviTum® and TK activity acknowledged in highly ren..
AQ
05/11BIOVICA INTERNATIONAL PUBL : provides market share target at today's Capital Mar..
AQ
05/06REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
05/06REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
05/06REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
05/06REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
04/29BIOVICA INTERNATIONAL PUBL : invites to virtual Capital Markets Day 11 May
AQ
04/08BIOVICA INTERNATIONAL PUBL : initiates a collaboration with Mayo Clinic to study..
AQ
03/25BIOVICA INTERNATIONAL PUBL : strengthens its commercial leadership
AQ
03/12BIOVICA INTERNATIONAL PUBL : DiviTum - first study published on CDK4/6 inhibitor..
AQ
03/10BIOVICA INTERNATIONAL PUBL : provides updates on FDA application
AQ
01/16BIOVICA INTERNATIONAL PUBL : Clinical Cancer Research publishes results supporti..
AQ
2019BIOVICA INTERNATIONAL PUBL : strengthens management team
AQ
2019Q2 INTERIM REPORT : Work with the FDA application progressing as planned
PU
2019Q2 INTERIM REPORT :  Work with the FDA application progressing as planned
AQ
2019BIOVICA INTERNATIONAL PUBL : DiviTum validated as a dynamic biomarker in metasta..
PU
2019BIOVICA INTERNATIONAL PUBL : DiviTum - Strong prognostic marker in operable brea..
AQ
2019BIOVICA INTERNATIONAL PUBL : DiviTum validated as a dynamic biomarker in metasta..
AQ